Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA

Regulatory Toxicology and Pharmacology

Volumn 88, Issue , 2017, Pages 192-213

  Lee, Peter N ^a   Fry, John S ^a   Hamling, John F ^a   Sponsiello Wang, Zheng ^b   Baker, Gizelle ^b   Weitkunat, Rolf ^b  

^a P N Lee Statistics and Computing Ltd   (United Kingdom)

^b PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Attributable risk; Harm reduction; Modelling; Reduced Risk Tobacco Product; Smoking

Indexed keywords

TOBACCO SMOKE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; HARM REDUCTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; MALE; MORTALITY RATE; POPULATION SIZE; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING; SMOKING CESSATION; UNITED STATES; EPIDEMIOLOGY; HEART DISEASE; LUNG TUMOR; MORTALITY; RECURRENT DISEASE; SUPPLY AND DISTRIBUTION; TOBACCO; UTILIZATION;

HEART DISEASES; HUMANS; LUNG NEOPLASMS; PREVALENCE; RECURRENCE; SMOKING; SMOKING CESSATION; STROKE; TOBACCO; TOBACCO PRODUCTS; UNITED STATES;

EID: 85021691996     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2017.06.009     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC), Cigarette smoking-attributable mortality and years of potential life lost - United States, 1990. MMWR Morb. Mortal. Wkly. Rep. 42:33 (1993), 645–649.
2. Food and Drug Administration, Guidance for Industry: Modified Risk Tobacco Product Applications. Draft Guidance, 2012, U.S. Department of Health and Human Services Food and Drug Administration Center for Tobacco Products. Guidance for Industry.
3. Forey, B., Lee, P., Estimation of sex-specific smoking statistics by standardized age groups and time periods. Supplement 1 to International Smoking Statistics, a Collection of Historical Data from 30 Economically Developed Countries, second ed., 2002, P N Lee Statistics and Computing Ltd, Sutton, Surrey Available www.pnlee.co.uk/Reports.htm [Download ISS2suppl1 FOREY2002C].
4. International smoking statistics. Forey, B., Hamling, J., Lee, P., Wald, N., (eds.) A Collection of Historical Data from 30 Economically Developed Countries, second ed., 2002, Wolfson Institute of Preventive Medicine and Oxford University Press, London and Oxford Errata available at www.pnlee.co.uk/ISS2.htm.
5. Forey, B.A., Thornton, A.J., Lee, P.N., Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm. Med., 11, 2011, 36, 10.1186/1471-2466-11-36.
6. Fry, J.S., Lee, P.N., Forey, B.A., Coombs, K.J., How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model. Regul. Toxicol. Pharmacol. 67 (2013), 13–26, 10.1016/j.yrtph.2013.06.001.
7. 1 - a review. Regul. Toxicol. Pharmacol. 67 (2013), 372–381, 10.1016/j.yrtph.2013.08.016.
8. Lee, P.N., Forey, B.A., Fry, J.S., Hamling, J.S., Hamling, J.F., Sanders, E.B., Carchman, R.A., Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD?. Inhal. Toxicol. 21:5 (2009), 404–430 Available: Supplementary material available at: www.pnlee.co.uk/Reports.htm [Download LEE2008L].
9. Lee, P.N., Forey, B.A., Coombs, K.J., Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer, 12, 2012, 385, 10.1186/1471-2407-12-385.
10. Lee, P.N., Fry, J.S., Hamling, J.S., Using the negative exponential distribution to quantitatively review the evidence on how rapidly the excess risk of ischaemic heart disease declines following quitting smoking. Regul. Toxicol. Pharmacol. 64 (2012), 51–67.
11. Lee, P.N., Fry, J.S., Forey, B.A., Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model. Regul. Toxicol. Pharmacol. 68:2 (2014), 231–239, 10.1016/j.yrtph.2013.12.006.
12. Lee, P.N., Fry, J.S., Thornton, A., Estimating the decline in excess risk of cerebrovascular disease following quitting smoking - a systematic review based on the negative exponential model. Regul. Toxicol. Pharmacol. 68:1 (2014), 85–95.
13. Lee, P.N., Hamling, J., Fry, J., Forey, B., Using the negative exponential model to describe changes in risk of smoking-related diseases following changes in exposure to tobacco. Adv. Epidemiol., 2015, Article ID 487876, 10.1155/2015/487876 13 pages.
14. Levy, D.T., et al. The application of a decision-theoretic model to estimate the public health impact of vaporized nicotine product initiation in the United States. Nicotine Tob. Res., 2016, 10.1093/ntr/ntw158 Epub ahead of print Jul 14 Published online: 20160714.
15. United Nations D.o.E.a.S.A, World Population Prospects: the 2012 Revision. Excel Tables - Population Data. 2013, United Nations, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section Available http://esa.un.org/wpp/Excel-Data/population.htm;http://esa.un.org/unpd/wpp/Documentation/pdf/WPP2012_HIGHLIGHTS.pdf;http://www.un.org/en/development/desa/population/publications/pdf/trends/WPP2012_Wallchart.pdf.
16. Nutt, D.J., et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur. Addict. Res. 20:5 (2014), 218–225, 10.1159/000360220.
17. Stanley, T.D., Massey, S., Evidence of nicotine replacement's effectiveness dissolves when meta-regression accommodates multiple sources of bias. J. Clin. Epidemiol., 2016, 10.1016/j.jclinepi.2016.03.024 Epub ahead of print Apr 11 Available http://www.jclinepi.com/article/S0895-4356(16)30075-0/abstract Published online: 20160411.
18. US Surgeon General, The Health Consequences of Smoking - 50 Years of Progress: a Report of the Surgeon General., 2014, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, Georgia Available http://www.surgeongeneral.gov/library/reports/index.html.
19. Weinberger, A.H., Pilver, C.E., Mazure, C.M., McKee, S.A., Stability of smoking status in the US population: a longitudinal investigation. Addiction 109:9 (2014), 1541–1553, 10.1111/add.12647.
20. Weitkunat, R., Lee, P.N., Baker, G., Sponsiello-Wang, Z., González-Zuloeta Ladd, A.M., Lüdicke, F., A novel approach to assess the population health impact of introducing a modified risk tobacco product. Regul. Toxicol. Pharmacol. 72 (2015), 87–93, 10.1016/j.yrtph.2015.03.011.
21. World Health Organization, WHO Mortality Database. Available, 2013 http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html;http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index1.html.